Keyphrases
Optical Coherence Tomography
100%
Therapeutic Window
100%
Gliomagenesis
100%
Optics
100%
Retinal Ganglion Cell Loss
100%
Retinal Dysfunction
100%
Temporal Course
100%
Optic Nerve
66%
Cellular Events
66%
Molecular Events
66%
Optic Pathway Glioma
66%
Lovastatin
66%
Retinal Nerve
66%
Layer Thinning
66%
Interleukin-1β
33%
Immunohistochemistry
33%
Microglia
33%
Microglial Activation
33%
Anesthetized Mice
33%
Age-matched
33%
Neurofibromatosis Type 1 (NF-1)
33%
Early Events
33%
Retina
33%
Treatment Completion
33%
Tumorigenesis
33%
Treatment Strategy
33%
S100
33%
Affected children
33%
Morphological Changes
33%
Glial Cells
33%
Genetically Engineered Mouse Models
33%
Vision Loss
33%
Axonal Injury
33%
Expression Change
33%
Live Animals
33%
Neuroprotective
33%
Human Specimen
33%
Euthanized
33%
Direct Measurement
33%
Cancer Predisposition Syndrome
33%
Neuroprotective Treatment
33%
GFAP-Cre
33%
Nerve Volume
33%
Retinal Ganglion Cell Apoptosis
33%
Therapeutic Discovery
33%
Reduced Visual Acuity
33%
Pharmacology, Toxicology and Pharmaceutical Science
Optic Nerve Glioma
100%
Therapeutic Window
100%
Neuroprotective Agent
100%
Mevinolin
100%
Biological Marker
50%
Mouse Model
50%
Interleukin 1
50%
Carcinogenesis
50%
Syndrome
50%
Genetically Engineered Mouse Strain
50%
Visual Impairment
50%
Axonal Injury
50%
Cancer Susceptibility
50%
Fox
50%
Medicine and Dentistry
Therapeutic Window
100%
Ganglion
100%
Microglia
75%
Cell Loss
75%
Optical Coherence Tomography
75%
Optic Nerve
50%
Neuroprotective Agent
50%
Optic Nerve Glioma
50%
Lovastatin
50%
Biological Marker
25%
Interleukin 1
25%
Immunohistochemistry
25%
Visual Acuity
25%
Visual Impairment
25%
Morphology
25%
Carcinogenesis
25%
Programmed Cell Death
25%
Cancer Susceptibility
25%
Axonal Injury
25%
Human Specimen
25%
Neuroscience
Retinal Ganglion Cell
100%
Microglia
75%
Cell Loss
75%
Optics
75%
Optic Nerve
50%
Neuroprotective Agent
50%
Lovastatin
50%
Immunohistochemistry
25%
Carcinogenesis
25%
Interleukin 1
25%
Programmed Cell Death
25%